BIT 0.00% 2.8¢ biotron limited

$10 Billion Deal, page-12581

  1. 5,990 Posts.
    lightbulb Created with Sketch. 243
    From the March Company Quarter report.

    The Company understands the high level of interest of shareholders in the outcomes of the completed clinical trials. Trials such as BIT225-011 that include longitudinal analyses of a multitude of immunological markers involve complex, time-consuming modeling and consultation with relevant experts. Good progress is being made and the Company looks forward to reporting results during the second quarter of 2024.

    We are past half way through the second quarter, so not long now.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
2.8¢
Change
0.000(0.00%)
Mkt cap ! $25.26M
Open High Low Value Volume
2.7¢ 2.8¢ 2.7¢ $3.64K 130.1K

Buyers (Bids)

No. Vol. Price($)
2 130927 2.7¢
 

Sellers (Offers)

Price($) Vol. No.
2.8¢ 55916 2
View Market Depth
Last trade - 14.19pm 05/09/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.